NanoViricides, Inc.

1.11 USD
-0.13 (-10.48%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

NanoViricides, Inc. stock is up 6.73% since 30 days ago. The next earnings date is May 13, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 63.16% of the previous 18 February’s closed higher than January. 100% of analysts rate it a buy.

About NanoViricides, Inc.

NanoViricides, Inc. discovers, develops, and commercializes drugs for the treatment of viral infections. Company develops Human Coronavirus Program for COVID-19 seasonal coronavirus affliction. Company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide.